My WebLink
|
Help
|
About
|
Sign Out
14b
City of Pleasanton
>
CITY CLERK
>
AGENDA PACKETS
>
2018
>
041718
>
14b
Metadata
Thumbnails
Annotations
Entry Properties
Last modified
4/12/2018 4:33:16 PM
Creation date
4/12/2018 4:33:13 PM
Metadata
Fields
Template:
CITY CLERK
CITY CLERK - TYPE
AGENDA REPORT
DOCUMENT DATE
4/17/2018
DESTRUCT DATE
15Y
There are no annotations on this page.
Document management portal powered by Laserfiche WebLink 9 © 1998-2015
Laserfiche.
All rights reserved.
/
41
PDF
Print
Pages to print
Enter page numbers and/or page ranges separated by commas. For example, 1,3,5-12.
After downloading, print the document using a PDF reader (e.g. Adobe Reader).
View images
View plain text
CERTIFICATIONS <br /> In accordance with the applicable statutes and the regulations governing the consolidated plan regulations, <br /> the jurisdiction certifies that: <br /> Affirmatively Further Fair Housing --The jurisdiction will affirmatively further fair housing, which means <br /> it will conduct an analysis of impediments to fair housing choice within the jurisdiction, take appropriate <br /> actions to overcome the effects of any impediments identified through that analysis, and maintain records <br /> reflecting that analysis and actions in this regard. <br /> Anti-displacement and Relocation Plan -- It will comply with the acquisition and relocation requirements <br /> of the Uniform Relocation Assistance and Real Property Acquisition Policies Act of 1970, as amended, and <br /> implementing regulations at 49 CFR 24; and it has in effect and is following a residential anti-displacement <br /> and relocation assistance plan required under section 104(d)of the Housing and Community Development <br /> Act of 1974, as amended, in connection with any activity assisted with funding under the CDBG or HOME <br /> programs. <br /> Drug Free Workplace -- It will or will continue to provide a drug-free workplace by: <br /> 1. Publishing a statement notifying employees that the unlawful manufacture, distribution, dispensing, <br /> possession, or use of a controlled substance is prohibited in the grantee's workplace and specifying <br /> the actions that will be taken against employees for violation of such prohibition; <br /> 2. Establishing an ongoing drug-free awareness program to inform employees about— <br /> a) The dangers of drug abuse in the workplace; <br /> b) The grantee's policy of maintaining a drug-free workplace; <br /> c) Any available drug counseling, rehabilitation, and employee assistance programs; and <br /> d) The penalties that may be imposed upon employees for drug abuse violations occurring in the <br /> workplace; <br /> 3. Making it a requirement that each employee to be engaged in the performance of the grant be given a <br /> copy of the statement required by paragraph 1; <br /> 4. Notifying the employee in the statement required by paragraph 1 that, as a condition of employment <br /> under the grant, the employee will— <br /> a) Abide by the terms of the statement; and <br /> b) Notify the employer in writing of his or her conviction for a violation of a criminal drug statute <br /> occurring in the workplace no later than five calendar days after such conviction; <br /> 5. Notifying the agency in writing, within ten calendar days after receiving notice under subparagraph 4(b) <br /> from an employee or otherwise receiving actual notice of such conviction. Employers of convicted <br /> employees must provide notice, including position title, to every grant officer or other designee on <br /> whose grant activity the convicted employee was working, unless the Federal agency has designated <br /> a central point for the receipt of such notices. Notice shall include the identification number(s) of each <br /> affected grant; <br /> 6. Taking one of the following actions, within 30 calendar days of receiving notice under subparagraph <br /> 4(b), with respect to any employee who is so convicted: <br /> DRAFT Annual Action Plan 32 <br /> 2018 <br /> OMB Control No:2506-0117(exp.07/31/2015) <br />
The URL can be used to link to this page
Your browser does not support the video tag.